The Latest Cardiac and Vascular News
– Study Led by John Mignone, M.D., Ph.D., Presented at the Heart Rhythm Society’s Annual Meeting – – Key Findings Demonstrate Increased Survival for Patients Receiving Combined Device and 4-Class Medical Therapy – ALISO VIEJO, Calif.–(BUSINESS WIRE)–egnite, Inc., a leading digital health company for cardiovascular care, announces today the release of novel research presented at Heart Rhythm […]
Expansion leverages a custom module to help health systems identify patients eligible for lifesaving therapy ALISO VIEJO, Calif.–(BUSINESS WIRE)–egnite, Inc., a leading digital health company for cardiovascular care, announces the expansion of its portfolio with the integration of a custom module designed to help physicians and health systems identify patients with atrial fibrillation (AF), deemed […]
Use of artificial intelligence technology efficiently identifies eligible patient candidates for pivotal clinical trial; program launched at The Christ Health Network SANTA CLARA, Calif. & ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a medical device company developing a novel transcatheter device-based therapy to address heart failure (HF), and egnite, Inc., a leading digital health company in the field of […]
– Two Bodies of Research Led by Philippe Généreux, MD and Colleagues were Presented Today at 2023 ACC Annual Meeting – – Key Findings Demonstrate Increased Mortality Across All Degrees of Severity of Aortic Stenosis, Suggesting the Need to Re-Evaluate Currently Recommended Timing of Intervention, and Highlight the Importance of the Extent of Cardiac Damage as the […]
Partnership leverages egnite’s artificial intelligence and big data expertise with Philippe Généreux and Linda Gillam from Morristown’s world-class Gagnon Cardiovascular Institute ALISO VIEJO, Calif.–(BUSINESS WIRE)–egnite, a digital healthcare company, announces a partnership with leading physicians from Morristown’s Gagnon Cardiovascular Institute, Philippe Généreux, a Director of the Structural Heart Program, and Linda Gillam, Chair of Cardiovascular […]
ALISO VIEJO, Calif.–(BUSINESS WIRE)–egnite, Inc., a leading digital-health company in the field of cardiovascular care, is proud to announce the appointment of Rahul P. Sharma, MD, MBBS, FRACP, as its new Senior Medical Advisor. A renowned interventional cardiologist, Sharma brings a wealth of knowledge and expertise to egnite’s executive team. With over a decade of experience […]
Company to focus on improving the quality of care for all cardiovascular patients in the U.S. ALISO VIEJO, Calif.–(BUSINESS WIRE)–On the heels of its landmark valvular heart disease (VHD) prevalence abstract published in Journal of the American College of Cardiology (JACC), egnite, Inc. today announced that it has expanded the company’s focus beyond structural heart disease into […]
– Data to Be Presented at 2022 ACC Annual Meeting Demonstrate Valve Disease is More Common in Women in the U.S. – – Other Key Findings Suggest Tricuspid and Mitral Regurgitation Have Highest Prevalence Rates; Severe Mitral Regurgitation Diagnosed More Frequently in Centers Offering Percutaneous Mitral Therapies – ALISO VIEJO, Calif.–(BUSINESS WIRE)–egnite, Inc., an advanced technology […]
AI-powered algorithms are proven to accurately predict the likelihood a patient with moderate AS has progressed to severe AS. ALISO VIEJO, Calif.–(BUSINESS WIRE)–egnite, Inc. presented new data at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 conference held November 4-6. The presentation showcased the proven accuracy and results of artificial intelligence (AI) powered algorithms to accurately predict […]
AI-powered algorithms provide physicians the tools to further elevate the standard of care for structural heart patients ALISO VIEJO, Calif.–(BUSINESS WIRE)–Building on its foundational strength in partnering with health systems to close gaps in care for structural heart patients, today egnite, Inc. launched a new suite of predictive algorithms for its CardioCare program. These algorithms […]
